Electronically monitored dosing histories can be used to develop a medication-taking habit and manage patient adherence

Expert Review of Clinical Pharmacology

Volumn 7, Issue 5, 2014, Pages 633-644

  Vrijens, Bernard ^a   Urquhart, John ^a   White, David ^b  

^a MWV Healthcare ^*  (Belgium)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

adherence; behavioral change; clinical pharmacology; habit; implementation; intervention; taxonomy

Indexed keywords

DEATH; DISEASE COURSE; ELECTRONIC MEDICAL RECORD; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH CARE SYSTEM; HOSPITALIZATION; HUMAN; MEDICAL HISTORY; PATIENT COMPLIANCE; PATIENT MONITORING; QUALITY OF LIFE; REVIEW; TAXONOMY; CLINICAL PRACTICE; FEEDBACK SYSTEM; MEDICATION COMPLIANCE; MEDICATION ERROR; METHODOLOGY; PREVENTION AND CONTROL; STANDARDS;

PRESCRIPTION DRUG;

ELECTRONIC HEALTH RECORDS; FEEDBACK; HEALTH CARE COSTS; HUMANS; MEDICATION ADHERENCE; MEDICATION ERRORS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTION DRUGS; QUALITY OF LIFE; RESEARCH DESIGN;

EID: 84906218359     PISSN: 17512433     EISSN: 17512441     Source Type: Journal    
DOI: 10.1586/17512433.2014.940896     Document Type: Review

References (54)

1. Blaschke TF, Osterberg L, Vrijens B, Urquhart J. Adherence. to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol 2012;52:275-301
2. WHO. Adherence to long-term therapies: evidence for action. WHO; Geneva, Switzerland: 2003
3. Burnier M, Wuerzner G, Struijker-Boudier H, Urquhart J. Measuring, analyzing, and managing drug adherence in resistant hypertension. Hypertension 2013;62(2):218-25
4. NEHI. Research brief: thinking outside the pillbox. New England Health Institute; Cambridge, UK: 2009
5. Haynes RB, Montague P, Oliver T, et al. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev 2000(2):CD000011
6. Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008(2):CD000011
7. Ahmed R, Aslani P. What is patient adherence? A terminology overview. Int J Clin Pharm 2014;36(1):4-7
8. Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 2012;73(5):691-705
9. Cole S, Seale C, Griffiths C. The blue one takes a battering' why do young adults with asthma overuse bronchodilator inhalers? A qualitative study. BMJ Open 2013;3:2
10. Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol 2013;4:91
11. Gossec L, Tubach F, Dougados M, Ravaud P. Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases: a systematic literature review. Am J Med Sci 2007; 334(4):248-54
12. Garber MC, Nau DP, Erickson SR, et al. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care 2004;42(7):649-52
13. Carroll CL, Feldman SR, Camacho FT, et al. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol 2004;51(2):212-16
14. Stone AA, Shiffman S, Schwartz JE, et al. Patient non-compliance with paper diaries. BMJ 2002;324(7347):1193-4
15. Arnsten JH, Demas PA, Farzadegan H, et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis 2001; 33(8):1417-23
16. Matsui D, Hermann C, Klein J, et al. Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator. J Clin Pharmacol 1994;34(9):944-9
17. Rudd P, Byyny RL, Zachary V, et al. The natural history of medication compliance in a drug trial: limitations of pill counts. Clin Pharmacol Ther 1989;46(2):169-76
18. Pullar T, Kumar S, Tindall H, Feely M. Time to stop counting the tablets? Clin Pharmacol Ther 1989;46(2):163-8
19. Halpern MT, Khan ZM, Schmier JK, et al. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension 2006; 47(6):1039-48
20. Vrijens B, Tousset E, Rode R, et al. Successful projection of the time course of drug concentration in plasma during a 1-year period from electronically compiled dosing-time data used as input to individually parameterized pharmacokinetic models. J Clin Pharmacol 2005;45(4):461-7
21. Kuypers DR, Peeters PC, Sennesael JJ, et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation 2013;95(2):333-40
22. Van Sickle D, Magzamen S, Truelove S, Morrison T. Remote monitoring of inhaled bronchodilator use and weekly feedback about asthma management: an open-group, short-term pilot study of the impact on asthma control. PLoS One 2013;8(2): e55335
23. Arnet I, Walter PN, Hersberger KE. Polymedication Electronic Monitoring System (POEMS) -a new technology for measuring adherence. Front Pharmacol 2013;4:26
24. Bruce JM, Hancock LM, Lynch SG. Objective adherence monitoring in multiple sclerosis: initial validation and association with self-report. Mult Scler 2010;16(1): 112-20
25. Demonceau J, Ruppar T, Kristanto P, et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs 2013;73(6):545-62
26. Vrijens B, Belmans A, Matthys K, et al. Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin. Pharmacoepidemiol Drug Saf 2006;15(2):115-21
27. Gross R, Bellamy SL, Chapman J, et al. Managed problem solving for antiretroviral therapy adherence: a randomized trial. JAMA Intern Med 2013;173(4):300-6
28. Reich WA. Medication adherence feedback intervention predicts improved human immunodeficiency virus clinical markers. Int J Nurs Pract 2013;19(6):577-83
29. Wu JR, Corley DJ, Lennie TA, Moser DK. Effect of a medication-taking behavior feedback theory-based intervention on outcomes in patients with heart failure. J Card Fail 2012;18(1):1-9
30. Van Camp YP, Vrijens B, Abraham I, et al. Adherence to phosphate binders in hemodialysis patients: prevalence and determinants. J Nephrol 2014. In press
31. Herzer M, Ramey C, Rohan J, Cortina S. Incorporating electronic monitoring feedback into clinical care: a novel and promising adherence promotion approach. Clin Child Psychol Psychiatry 2012;17(4): 505-18
32. Sutton S, Kinmonth AL, Hardeman W, et al. Does Electronic Monitoring Influence Adherence to Medication? Randomized Controlled Trial of Measurement Reactivity. Ann Behav Med 2014. [Epub ahead of print]
33. Feldman S. Overcoming the forgetfulness problem. PM360. 2013. Available from: www.pm360online.com/physician-povovercoming-the-forgetfulness-problem/
34. Osterberg LG, Urquhart J, Blaschke TF. Understanding forgiveness: minding and mining the gaps between pharmacokinetics and therapeutics. Clin Pharmacol Ther 2010;88(4):457-9
35. Cramer JA. Enhancing patient compliance in the elderly. Role of packaging aids and monitoring. Drugs Aging 1998;12(1):7-15
36. Cramer JA, Rosenheck R. Enhancing medication compliance for people with serious mental illness. J Nerv Ment Dis 1999;187(1):53-5
37. Vrijens B, Vincze G, Kristanto P, et al. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008;336(7653):1114-17
38. Duhigg C. Power of habit: why we do what we do in life and business. Random House Books; NY, USA: 2012
39. Saberi P and Johnson MO. Technology-based self-care methods of improving antiretroviral adherence: a systematic review. PLoS One 2011;6(11): e27533
40. Easthall C, Song F, Bhattacharya D. A meta-analysis of cognitive-based behaviour change techniques as interventions to improve medication adherence. BMJ Open 2013;3:8
41. de Bruin M, Hospers HJ, van Breukelen GJ , et al. Electronic monitoring-based counseling to enhance adherence among HIV-infected patients: a randomized controlled trial. Health Psychol 2010;29(4): 421-8
42. US FDA. Guidance for Industry. Enrichment strategies for clinical trials to support approval of human drugs and biological products. Available from: www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ UCM332181.pdf
43. Mahtani KR, Heneghan CJ, Glasziou PP, Perera R. Reminder packaging for improving adherence to self-administered long-term medications. Cochrane Database Syst Rev 2011(9):CD005025
44. Zedler BK, Kakad P, Colilla S, et al. Does packaging with a calendar feature improve adherence to self-administered medication for long-term use? A systematic review. Clin Ther 2011;33(1):62-73
45. Zedler BK, Joyce A, Murrelle L, et al. A pharmacoepidemiologic analysis of the impact of calendar packaging on adherence to self-administered medications for long-term use. Clin Ther 2011;33(5): 581-97
46. Dupclay L, Eaddy M, Jackson J, et al. Real-world impact of reminder packaging on antihypertensive treatment adherence and persistence. Patient Prefer Adherence 2012;6:499-507
47. HCPC. Improving medication adherence through packaging. Available from: www.hcpconline.org/member-news-document/HCPC-White-Paper-Improving-Medication- Adherence-with-Packaging.pdf
48. Schoenthaler A, Ogedegbe G. Patients' perceptions of electronic monitoring devices affect medication adherence in hypertensive African Americans. Ann Pharmacother 2008;42(5):647-52
49. El-Sadr WM, Philip NM, Justman J. Letting HIV transform academia-embracing implementation science. N Engl J Med 2014;370(18):1679-81
50. Burnier M, Schneider MP, Chiolero A, et al. Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens 2001; 19(2):335-41
51. Marin D, Bazeos A, Mahon FX, et al. Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib. J Clin Oncol 2010;28(14):2381-8
52. de Bruin M, Viechtbauer W, Schaalma HP, et al. Standard care impact on effects of highly active antiretroviral therapy adherence interventions: a meta-analysis of randomized controlled trials. Arch Intern Med 2010; 170(3):240-50
53. Michie S, Richardson M, Johnston M, et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med 2013;46(1):81-95
54. Oberje EJ, de Kinderen RJ, Evers SM, et al. Cost effectiveness of medication adherence-enhancing interventions: a systematic review of trial-based economic evaluations. Pharmacoeconomics 2013; 31(12):1155-68